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All cardiovascular procedures present unique risks, and such risks may affect a particular patient’s outcome. 
Outcome report data presented in this report is from Maine Medical Center. 
The photos in this report were taken prior to COVID-19 and do not reflect MaineHeath’s current masking and social distancing requirements.






The MaineHealth system is a partnership 
of physicians and hospitals, listed below, 
dedicated to improving the cardiovascular 
health of the residents of northern New 
England. Our vision includes being a 
premier provider of accessible, cost effective, 
coordinated and compassionate care; and 
putting our patients’ needs first, delivering 
superior clinical outcomes and excellence in 
education and clinical research. The program 
is committed to achieving surgical outcomes 
that exceed national benchmarks.
CARDIOVASCULAR MEDICINE
• Advanced Heart Failure
• Cardiac Arrhythmia 
• Cardio-Oncology 
• Disease Prevention 
• Imaging and Diagnostics 
• Coronary Revascularization
• Hypertrophic Cardiomyopathy 
• Sports Cardiology 
CARDIOVASCULAR SURGERY 
• Cardiac Valve 
• Coronary Revascularization 
• Advanced Heart Failure 
VASCULAR SURGERY 
• Aortic Disease 
• Carotid Revascularization 
• Comprehensive Vein 
• Limb Salvage 
• Rare Vascular Conditions 
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I am honored to be part of Cardiovascular Services at 
MaineHealth — an integrated network of hospitals, 
health care providers and specialists — built with patients’ 
needs at the very center. We provide comprehensive heart 
care to Maine and Mt. Washington Valley residents 
through a coordinated system designed to achieve the 
best possible cardiac and vascular outcomes. 
For over 60 years, we have worked diligently to become one 
of the premier cardiovascular networks in New England 
and the largest in northern New England. Our teams 
of dedicated physicians, advanced practitioners, nurses, 
clinical and technical staff  and administrators takes great 
pride in what they do every day to provide the best care 
for patients. We have a long tradition and commitment to 
empowering caregivers at all levels to provide the highest 
quality patient care and service to cardiovascular patients.
Our service line combines medical and surgical services 
(both inpatient and ambulatory care), along with research 
and education, under unified clinical and administrative 
leadership. Our intent is to highlight our strong 
performance as evidenced by the data presented clearly 
and transparently on the following pages. This report 
highlights many of our treatment offerings and leading 
technologies in use across MaineHealth.
For example, MaineHealth aims to help people with 
heart failure have the best possible clinical outcomes 
and quality of life. To achieve this, our organizations 
and partners implemented a variety of evidence-based 
treatments across MaineHealth and in every care setting 
in order to provide care as close to home as possible. This 
approach helps patients manage heart failure symptoms 
better; as a result, they need to be hospitalized less often. 
Care settings include patients’ private homes, nursing care 
facilities, medical care offices, emergency departments 
and hospitals. Treatment options include evidence-based 
clinical pathways, supporting clinical decision tools, 
providing patients with clear and consistent plans of care 
and specialized care for patients with advanced disease.   
To enable a more seamless transition across the care 
continuum, Cardiovascular Services activated our shared 
electronic health record, Epic’s Cupid application, in 
February 2020. I would like to thank the cardiologists 
and physician leaders, along with other staff people who 
dedicated their time, talent and expertise to this effort. 
This large project included practice managers, support 
teams and information technology teams that invested 
countless hours partnering with our clinicians to ensure the 
readiness of the technical infrastructure, validating clinical 
and administrative workflow and training subject matter 
experts. The success of this complex implementation is the 
result of outstanding teamwork, project management and 
leadership across our hospitals and physician practices.
I invite you to collaborate and partner with us as we 
continue to strive to improve cardiovascular care, 
quality and patient access, while delivering the best 
health outcomes and developing a systematic approach 
that serves the residents of Maine and southern New 
Hampshire, as well as visitors to northern New England.
Marco Diaz, MD 
Chair of the Department of Cardiovascular Medicine 
Chief of MaineHealth Cardiovascular Services
Marco Diaz, MD, was named as the new Chair of the 
Department of Cardiovascular Medicine and Chief of the 
MaineHealth Cardiovascular Services in early 2020. Dr. Diaz is 
recognized by peers and colleagues as an outstanding clinician 
and educator. For the past five years, he served as Senior 
Medical Director, overseeing the development of a system-
wide cardiology practice. At the same time, he has been a 
primary driver in the programmatic growth of cardiac services. 
Dr. Diaz continues his contribution to MMC by fostering the 
clinical, educational and research growth of cardiovascular 
medicine at the institution.
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NEW ADULT CONGENITAL CARDIOLOGY PROGRAM
People with congenital heart disease need care throughout their lives. From infancy through adulthood, people with 
congenital heart issues are best served by specially trained clinicians who understand their complex and unique needs. 
Our program offers a full range of inpatient and outpatient clinical services — from diagnosis to surgical repair. We care 
for pediatric and adult patients with all forms of congenital heart conditions and pulmonary hypertension issues. In 2019, 
MaineHealth launched a new program for adult patients with any form of congenital heart condition. This includes those 
with newly diagnosed congenital heart defects, as well as those with complex congenital heart disease who may have 
received care since childhood and now may require transition to adult medical services such as family planning, genetic 
counseling and ongoing cardiology care.
HEALTH RECORD 
FOLLOWS PATIENT
When it comes to 
delivering high-quality 
patient care, an integrated 
electronic health record 
that follows your patient 
matters. Last year, Mike 
Knof was out grocery 
shopping in Damariscotta 
when he experienced 
cardiac arrest and 
collapsed to the ground. After receiving chest 
compressions from nearby community members, he 
was rushed to LincolnHealth - Miles Campus, where 
the ER team stabilized him and transported him to 
MMC. Mike’s medical records were already there 
when he arrived. 
MMC cardiologist Dr. Jeremy Estrada was part of the 
cardiac team when Mike was rushed in. Because 
LincolnHealth and MMC use Epic applications, Dr. 
Estrada was able to see Mike’s full medical history 
and medication list and to act quickly, using the 
newest technology and collective expertise of his 
team. He performed an angiogram and a right heart 
catheterization, and also used a special kind of 
imaging that revealed Mike’s blockage had not caused 
a heart attack. So instead of a stent, Dr. Estrada put 
in a balloon pump. “Because we were on the same 
electronic health record, we could view Mike’s full 
record, allowing us to anticipate and predict how 
sick he was,” said Dr. Estrada. “This enabled us to 
provide him with the care he needed and the care 
Mike needed to heal after the procedure.”
Mike Knof,
cardiac patient
“ONE PATIENT, ONE RECORD” ACROSS THE 
CONTINUUM OF CARE
MaineHealth achieved an exceptional milestone 
this year: the successful activation of our shared 
electronic health record. The implementation of the 
Epic cardiology ambulatory and Cupid applications 
was the culmination of a coordinated, multifaceted 
effort that engaged hundreds of dedicated leaders 
and teams across our health system.
This implementation puts the patient at the center of 
care. Now, any clinical caregiver of a MaineHealth 
cardiac patient has access to health information in one 
central location. This supports improved efficiencies, 
better transitions of care and flow of patient 
information and superior clinical outcomes. This 
milestone implementation will bring several benefits 
to providers and patients:
• Gives our cardiology care teams access to a fully 
integrated health record.
• Improves medication reconciliations and patient 
safety.
• Reduces variability and standardizes Epic 
tools and functionality already implemented at 
MaineHealth organizations.
• Gives all cardiac patients across our health system 






HEART FAILURE AND MECHANICAL CIRCULATORY SUPPORT 
Our Advanced Heart Failure Program at MMC is made up of a multidisciplinary team of cardiologists, cardiac 
surgeons, advanced practice providers and nurses, and supported by experts in all disciplines to manage patients 
throughout all stages of heart failure. The team employs the most recent medical and surgical therapies for cardiogenic 
shock and heart failure. These therapies include mechanical circulatory support devices such as extracorporeal 
membrane oxygenation (ECMO), temporary percutaneous ventricular assist devices to support both the right and left 
ventricles, and durable implantable left ventricular assist devices (LVAD). Durable LVADs are used to help patients 
with advanced heart failure restore circulation and improve functional capacity. These devices can be employed to 
sustain patients awaiting heart transplantation, as well as patients not able to receive transplants. 
CARDIAC ARRHYTHMIAS 
The MaineHealth Cardiac Arrhythmia Program supports patients with problems in the electrical function of the 
heart that cause abnormal heart rhythms (arrhythmias). The program is ever-evolving to address the changing 
arrhythmia needs of our communities. MMC has become a high-volume tertiary referral center for northern 
New England, managing both simple and complex arrhythmias including atrial fibrillation, supraventricular and 
ventricular tachycardia, atrial flutter, premature ventricular contractions and Wolff-Parkinson-White syndrome.  
MMC achievements include:
• The first hospital in Maine to perform the convergent procedure for patients suffering with persistent atrial 
fibrillation (A-fib), who may have failed other treatment modalities. 
• Achieved the American Heart Association’s Get with the Guidelines: A-fib Gold Award for 2019.
Our electrophysiology (EP) specialists are available for consultation at MaineHealth hospitals and practice offices 
across the system service area.
VOLUME 
MECHANICAL CIRCULATORY SUPPORT 
2017 2018 2019
LVAD IMPLANTS 14 14 10
PERCUTANEOUS LVAD 10 10 19
ECMO 20 21 29
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MMC was the first hospital in the state to perform the convergent procedure for 
patients suffering with long-standing persistent A-fib who may have failed other 
treatment modalities. MMC is the only hospital in Maine to offer percutaneous 
occlusion of the Left Atrial Appendage (LAA) with the WatchmanTM device for patients 
at high risk for stroke and who are considered suitable for short-term Warfarin use but 
with reason to seek an alternative (such as high risk of bleeding). Our electrophysiology 




















































ATRIAL FIBRILLATION ABLATION METRICS*
% OF PATIENTS IN NRS (NORMAL SINUS RHYTHM) AT 6-MONTH FOLLOW-UP 94.3%
% OF PATIENTS WITHOUT COMPLICATIONS FOLLOWING ABLATION PRIOR TO 
DISCHARGE 96.3%
SURVIVAL AT 6-MONTH FOLLOW-UP AFTER ABLATION PROCEDURE 100%
SYMPTOM-FREE AT 6-MONTH FOLLOW-UP 73.5%










NUMBER OF PATIENTS 42 100% 24,530 100%
ALIVE AT DISCHARGE 42 100% 24,473 99.8%
PROCESS METRICS (PROPORTION OF)
PATIENTS EVALUATED FOR STROKE RISK USING 
THE CHA2DS2-VASC SCORE 42 100% 24,463 99.7%
PATIENTS EVALUATED FOR BLEEDING RISK 
USING THE HAS-BLED SCORE 42 100% 24,463 99.7%
OUTCOME METRICS (PROPORTION OF)
LAAO (LEFT ATRIAL APPENDAGE OCCLUSION) 
PROCEDURES SUCCESSFUL 39 92.9% 22,370 91.2%
LAAO PROCEDURES SUCCESSFUL EXCLUDING 
THOSE PROCEDURES CANCELED 39 95.1% 22,370 93.7%
PATIENTS WITH A MAJOR COMPLICATION 
EITHER INTRA OR POST PROCEDURE AND 
PRIOR TO DISCHARGE
3 2.1% 647 2.6%
PATIENTS EXPERIENCING A DISABLING OR LIFE 
THREATENING BLEEDING EVENT INTRA OR 
POST PROCEDURE AND PRIOR TO DISCHARGE
0 0% 60 0.2%
PATIENTS WHO EXPERIENCE A STROKE 
(ISCHEMIC OR HEMORRHAGIC), OR SYSTEMIC 
EMBOLISM, OR MORTALITY INTRA OR POST 
PROCEDURE AND PRIOR TO DISCHARGE
0 0% 83 0.3%
PATIENTS WITH AN ISCHEMIC STROKE 
OR SYSTEMIC EMBOLISM INTRA OR POST 
PROCEDURE AND PRIOR TO DISCHARGE
0 0% 23 0.1%
MEDIAN LENGTH OF STAY (DAYS) 1 1
*Source: NCDR LAAO Registry, Q4 2018 to Q3 2019
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AMERICAN COLLEGE OF CARDIOLOGY NCDR ICD REGISTRY
Since its inception in 2005, the ICD Registry has been the national standard for understanding patient selection, care and 
outcomes in patients receiving implantable cardioverter defibrillator (ICD) therapy. The ICD Registry empowers EP physicians 






COMPOSITE: PROPORTION OF ICD/CRT-D 
IMPLANTS PRESCRIBED ALL DISCHARGE 
MEDICATIONS FOR WHICH THEY WERE 
ELIGIBLE
95.2% 89.5% 98.1%
PROPORTION OF ICD/CRT-D PATIENTS THAT 
FULFILL CLASS IA , IIA, OR IIB GUIDELINES 90.9% 84.6% 97.8%
*Source: ICD Registry Rolling Four Quarters Ending Q2 2018
CARDIAC VALVE DISEASE
We offer comprehensive management and treatment options for cardiac valve disease, including aortic, mitral and 
tricuspid valve disease. MaineHealth physicians are at the forefront of valve dysfunction and have worked collaboratively 
to build upon the traditional surgical approach with emerging less-invasive technologies (such as transcatheter) for 
the treatment of both aortic and mitral valves. 
Open surgical aortic valve replacement/repair (SAVR) has been the standard for aortic valve disease. Transcatheter 
aortic valve replacement (TAVR) is a minimally invasive, catheter-based procedure to replace the aortic valve with severe 
aortic stenosis. As an alternative to SAVR, the TAVR procedure was developed for intermediate and high-risk patients 
who were not candidates for an open surgical procedure. However, TAVR is now available for lower-risk patients. 
Repairing a patient’s mitral valve can return the patient to the quality of life they experienced prior to the onset of mitral 
valve disease. Performing these repairs before the disease progresses may prevent future life-threatening conditions. 
Less invasive, catheter-based approaches to mitral valve repair are now emerging, and MMC offers eligible patients 




MMC formed a mitral valve clinic in 2019 with a vision to provide advanced services spanning the continuum of care and 
offering cutting-edge individualized care to patients with primary and secondary mitral valve disease. According to cardiac 
surgeon Michael Robich, MD, the MMC clinic will build on the extensive and established experience of both Maine Medical 
Partners — MaineHealth Cardiology and Maine Medical Partners — Cardiovascular Surgery as regional leaders in complex 
surgical and minimally invasive mitral valve procedures. A multidisciplinary team is working to establish the region’s first 
Mitral Center of Excellence to provide even more advanced surgical, minimally invasive and endovascular treatments for 
all types of mitral valve disease. 
TAVR OUTCOMES
2018 2019*
TAVR PROCEDURES 200 226
IN-HOSPITAL MORTALITY (UNADJUSTED) 0.5% 1.0%
TVT REGISTRY AVERAGE 1.3% 1.0%
STROKE 3.0% N/A
TVT REGISTRY AVERAGE 1.8%
AORTIC REGURGITATION
(MODERATE TO SEVERE) AT 30 DAYS 0.0% 0.0%
TVT REGISTRY AVERAGE 0.0% 1.0%
SIGNIFICANT CARDIAC EVENTS 0.0% 0.4%
TVT REGISTRY AVERAGE 0.9% 0.5%
Source: STS/ACC/TVT Registry
*Rolling Four Quarters Ending Q2 2019
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AMI PERFUSE 
Our AMI PERFUSE (Acute Myocardial Infarction Patients Emergently Re-perfused by Facilities United for 
STEMI Excellence) Program has been in place since 2004, with a goal of providing the highest level of care with the 
best possible outcomes for patients experiencing an ST-elevation myocardial infarction, regardless of the patient’s 
location. Approximately 65% of STEMI patients are initially seen at other hospitals and transferred to MMC for 
cardiac catheterization and management. In most cases, these patients are given thrombolytic medication to open 
their arteries and restore blood flow to the heart. STEMI patients seen at hospitals close to MMC are stabilized and 
transferred to the MMC cardiac catheterization lab for immediate percutaneous coronary intervention (primary PCI).
CORONARY ARTERY DISEASE AND REVASCULARIZATION 
MaineHealth coronary revascularization services help people who require heart bypass surgery. We specialize in coronary 
artery bypass graft (CABG) procedures and percutaneous coronary intervention, such as coronary angioplasty and stent 
placement. Coronary revascularization services help restore blood flow to hearts with diseased arteries (coronary artery disease). 
Maine Medical Center doctors performed Maine’s first coronary artery bypass surgery over 40 years ago. Today, MMC 
not only performs more of these procedures than any other hospital in Maine, but also more than most hospitals in all New 
England. Many coronary artery disease cases can now be diagnosed and treated with a minimally invasive technique known 
as cardiac catheterization or “cath.” More than 5,000 cath procedures (such as angiograms, angioplasties and stent placements) 
are performed each year in MMC’s state-of-the-art cath lab, making it one of the highest-volume facilities in New England.
INVASIVE / INTERVENTIONAL CARDIOLOGY 
Our interventional cardiologists provide other 
diagnostic services including hemodynamic 
assessments for patients with heart failure, valve disease, 
pulmonary hypertension and pericardial disease. 
Endomyocardial biopsies are performed in select 
patients for evaluation of cardiomyopathy and cardiac 
transplant rejection. The team also performs high-
risk percutaneous coronary interventions including 
left main artery stenosis in patients at increased risk 
for surgery, and on those vessels with chronic total 
occlusion. A full range of mechanical support devices is available to prevent or treat cardiogenic shock, including 











CASES MEETING REPERFUSION GOALS 
D2LYTIC LESS THAN 30 MINUTES 70.9% 100 of 141 cases
D2B LESS THAN  90 MINUTES 97.0% 98 of 101 cases




STEMI PCI 283 329
% TOTAL PCI PROCEDURES 21.40 % 19.70%
ACC-NCDR AVERAGE 16.80% 17.00%
STEMI RISK-ADJUSTED MORTALITY 6.30% 3.21%
ACC-NCDR 50TH PERCENTILE 7.01% 6.45%
PCI EXCLUDING STEMI RISK-ADJUSTED 
MORTALITY 0.72% 0.60%
ACC-NCDR 50TH PERCENTILE 1.09% 1.07%
PCI RISK ADJUSTED MORTALITY (ALL) 1.68% 1.04%
ACC-NCDR 50TH PERCENTILE 2.03% 1.96%
Source: ACC-NCDR American College of Cardiology National Cardiovascular Data Registry
In 2019, 1,593 percutaneous coronary interventions (PCI) were performed at MMC. National trends continue to 
see lower numbers of PCIs, potentially due to more aggressive and successful medical management of coronary 
artery disease versus immediate intervention.
The treatment of cardiovascular disease for most patients begins and ends in the clinic where cardiologists and advanced 
practice providers evaluate and treat patients. Our providers work collaboratively with primary care and other cardiology 
providers in northern New England to ensure patients in our communities have timely access to expert clinical care as 
well as outpatient diagnostic services.
12
CARDIAC IMAGING AND DIAGNOSTICS 
Our Cardiac Imaging and Diagnostics Program provides nationally recognized services to patients. The 
multidisciplinary team of physicians, technologists and staff provide state-of-the-art diagnostic services utilizing 
cutting-edge multimodality technologies. We perform the highest volume of services in the state, including the 
management of complex, unusual cardiovascular diseases as well as common problems, all with a focus on the 
patient. Our specialists have expertise in imaging for ischemic, valvular, vascular and congenital cardiovascular 
disease. Additionally, cardiac MRI, PET and CT services are offered. MMC has the only dedicated PET perfusion 
program in northern New England, imaging sarcoidosis and myocardial viability. 
Many services are available at regional hospitals across our health system so that heart patients can access care 
close to home.
Maine Medical Partners  — MaineHealth Cardiology was one of the first practices in Maine to offer in-office 
insertion of the Reveal LINQ Insertable Cardiac Monitor, an advanced cardiac monitor that allows physicians 
to continuously and wirelessly monitor a patient’s heartbeat for up to three years. Physicians typically implant 
cardiac monitors in the hospital setting due to past reimbursement guidelines; however, new reimbursement 
coverage allows us to perform the procedure in the office setting. In-office procedures are another way for patients 
to gain access to the long-term monitoring they need.
SPORTS CARDIOLOGY
The MaineHealth Sports Cardiology Program is the only one in the state dedicated to the care of the athlete’s 
heart. We offer specialized cardiac care to athletes and highly active individuals, whether they have symptoms 
suggestive of cardiovascular disease or an established cardiovascular diagnosis. Our goal is to keep athletes 
healthy so they can remain active in sports. In addition to training in heart disease diagnosis and treatment, our 
sports cardiologists have specialized expertise in the physical demands of competitive sports and the psychology 
of athletes. The program offers a full spectrum of diagnostic testing, including cardiac imaging, comprehensive 
physiologic assessment using cardiopulmonary exercise testing and access to other cardiac services. We provide 
recommendations for appropriate activity levels and symptom management for each athlete — helping them 
make decisions about when and how they can safely resume participation in their sport. 
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HEART CARE BEATS WITH EMOTIONAL SUPPORT 
New program is valuable after a heart event
MMC physicians work hard every day to restore the physical health of patients with heart 
disease. According to Marco Diaz, MD, the “emotional challenges of being diagnosed with 
and living with heart conditions can be life-altering as well.” Aimee Reilly, LCSW, is helping 
patients, family members and physicians learn about how to restore emotional health. “Her 
expertise has ensured that no one faces heart disease alone or without the support they need,” 
said Dr. Diaz. 
In our integrated program, Aimee communicates frequently with cardiologists about patients’ questions, concerns and 
symptoms, and updates them on patients’ behavioral health treatment goals. Research has shown that major depressive 
disorder rates for patients following myocardial infarction are approximately 20%, about triple the rate for the general 
population. A patient with depression may not be taking their medications as prescribed, may not be practicing a healthy 
lifestyle, or could be utilizing smoking or alcohol to cope — all of which could negatively impact the patient’s cardiac 
condition. “It is important for patients to know that significant changes in mood following cardiac events is common, 
treatable and equally as important to address as their physical needs,” Aimee explained. “The health care industry 
increasingly recognizes the importance of behavioral health in connection with a patient’s medical well-being. Our program 
expanded into cardiology as cardiologists recognized their patients’ need for behavioral support.”




Cardiac rehabilitation (or rehab) programs help people with heart issues make healthy lifestyle choices to reduce 
the risk of future heart problems. Services include nutrition counseling, graduated exercise training, stress 
reduction education and more. MaineHealth offers cardiac rehab services at multiple locations across the state. 
MMC’s cardiac rehabilitation offering, Turning Point, is an outpatient program located at Maine Medical Partners 
— MaineHealth Cardiology in Scarborough. The program consists of four phases:
• Phase 1 is a visit to inpatients at MMC for education on risk-factor modification and outpatient cardiac rehab 
program enrollment. 
• Patients return to our facility in Scarborough, or the closest facility our team can assign, to initiate Phase 2, a 
program of outpatient services that includes education and exercise sessions three times per week. 
• We offer a Phase 3 outpatient program to Phase 2 graduates, or others with specific medical conditions who 
may benefit from a medically supervised exercise program. 
• Finally, we encourage all our patients to participate in Phase 4, a program of independent exercise at a community-
based fitness center or gym.
Walk with a Doc, a national program started by a cardiologist, was introduced 
in May 2019 to support patients in cardiac rehabilitation at Turning Point. 
Before monthly walks, our providers offer education sessions about heart 
issues. Pictured Jeffrey Rosenblatt, MD, walks with patient in Scarborough.
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VOLUME GROWTH AT TURNING POINT CARDIAC REHABILITATION 
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Source: Circ Cardiovasc Qual Outcomes 2020; 13:e005902. DOI: 10.1161/
CIRCOUTCOMES.119.005902  January 2020
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MMC cardiac surgeon Walter 
DeNino, MD, onboard LifeFlight. 
LifeFlight and MMC’s ECMO 
team created protocols 
and procedures, along with 
developing a standardized team 
for specialized transports.
CARDIOVASCULAR SURGERY
MaineHealth offers the state’s most comprehensive resources for cardiac surgery. Our highly skilled cardiothoracic 
surgeons provide each patient with an individualized plan of care to best suit that patient’s needs. The cardiac surgical 
team consists of cardiac surgeons who work with cardiac anesthesiologists, perfusionists, physician assistants, cardiac 
operating room staff and nursing and critical care staff who care for the patient after the operation. Our program 
has been recognized by U.S. News & World Report as a Best Regional Hospital and “high performing” in bypass 
and aortic valve surgery. 
• Other areas of expertise include our elective and emergent thoracic aortic procedures, mechanical circulatory 
support and surgery for atrial fibrillation. We manage all aspects of this progressive disease, including acute and 
chronic cases, and patients with known or suspected connective tissue diseases.
• MMC is the only hospital in Maine performing EKG-gated CT angiography, which offers the most accurate 
assessment of the thoracic aorta. 
• High surgical volume has been shown to improve the outcomes in transcatheter valve procedures. Cardiac 
surgeons at MMC have unparalleled experience in heart valve surgery, performing more of these surgical 
procedures than at any other hospital in Maine. 
• The advanced valve team is comprised of cardiologists and surgeons who work closely with heart failure 
specialists, radiologists and palliative care staff to deliver personalized care whether that involves surgery, 
transcatheter treatments or optimal medical management. The team is available to assess patients who are high- 
or prohibitive-risk candidates for intervention.
17
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REPAIR 37 57 63






















STS AVERAGE 2.00% 1.90%
AVR + CABG 1.40% 2.10%





STS AVERAGE 1.20% 1.10%
MVRP + CABG 0.00% 11.10%
STS AVERAGE 5.30% 4.50%
*The Society of Thoracic Surgeons
18
Elizabeth Blazick, MD, Maine 
Medical Partners — Surgical 
Care, discusses carotid artery 
disease with a patient. We provide 
patients with carotid artery 
disease access to comprehensive, 
state-of-the-art treatments 
including carotid endarterectomy, 
artery stenting (trans-femoral and 
TCAR), artery aneurysm surgery, 
body tumor surgery and artery 
fibromuscular dysplasia.
VASCULAR DISEASE AND SURGERY
AORTIC, PERIPHERAL AND 
INTERVENTIONAL RADIOLOGY
Our vascular services staff is committed to continuous 
improvement. To aid with this effort, we subscribe to nine 
registries that allow us to benchmark our performance 
against our peers across the U.S.: Carotid Artery 
Stent, Carotid Endarterectomy, Endovascular AAA 
Repair, Lower Extremity Amputation, Infra-inguinal 
Bypass, Supra-inguinal Bypass, Open AAA, Peripheral 
Vascular Intervention and Thoracic and Complex 
EVAR (including Endovascular Thoracic Stenting and 
treatment for penetrating aortic ulcers and dissections). 
An important aspect of improving the quality of vascular 
care is achieved through a commitment to seeing the 
patient at a long-term follow-up visit, nine to 21 months 
after one of these procedures.
Patients are treated in state-of-the-art facilities, such as 
our cutting-edge hybrid operating suite, and have access 
to the most advanced treatments, including clinical trials 



















MaineHealth offers the most-advanced vascular surgery services in Maine — both open and endovascular. Our team of 
highly skilled specialists includes cardiologists, vascular surgeons, interventional radiologists and diagnostic radiologists, 
all working together to evaluate and treat each patient. Vascular surgery includes treatment for thoracic aortic aneurysms, 
abdominal aortic aneurysms and aneurysms of the arteries.
QUALITY MEASURES
2018 2019
ALL AAA REPAIRS / DEATH DURING HOSPITALIZATION 86 / 5.8% (5) 70 / 2.9% (2)
ALL CAROTID REVASCULATION / NEW STROKE 203 / 3.4% (7) 256 / 2.7% (7)
LOWER EXTREMITY / AMPUTATION DURING HOSPITALIZATION N/A 499 / 2.9% (9)
NEW JOINT 
VEIN PROGRAM
Our medical Vein Clinic 
in southern Maine is a 
joint partnership between 
Maine Medical Partners — 
MaineHealth Cardiology 
and Maine Medical 
Partners — Surgical 
Care/Vascular Surgery. 
Services include laser vein 
ablation, radiofrequency 
vein ablation, ClariVein, 
phlebotomy, ligation and 
sclerotherapy.
Physician Assistant Julie Savatelli in the Vein Clinic, Scarborough.
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CARE TEAMS—ADVANCED PRACTICE PROVIDERS, CARDIAC ANESTHESIOLOGY AND NURSING
Advanced practice providers (APPs), including nurse practitioners and physician assistants, are an integral 
component of the ambulatory and hospital care teams within Cardiovascular Services. Team-based care is paramount 
to transforming cardiovascular care and improving heart health. As more patients receive team-based care from 
both a physician and an APP, research indicates the joint approach may improve quality of care as well as access to 
care for patients.
Cardiac surgery APPs provide 24/7 comprehensive care in the operating room as first assistants, in the cardiothoracic 
intensive care unit and in the cardiac surgery step down unit. Vascular surgery APPs provide care for patients in the 
hospital setting, including OR first assist and patient care in the surgical units as well as pre- and post-hospital care 
in the ambulatory setting. Cardiology APPs provide direct care and support to cardiology inpatients (both medical 
and procedural), while a separate group of APPs provides direct care to cardiology patients seen in the cardiology 
ambulatory setting. 
The cardiac anesthesiology group is comprised of physicians providing around-the-clock specialty anesthesia services 
for our cardiac surgery patients. All are experts in managing the special needs of the cardiac patient who requires 
anesthetic care. Furthermore, our cardiac anesthesiologists have proven special competence in advanced intraoperative 
echocardiography and provide real-time intraoperative imaging services. Our anesthesiologists work closely with 
cardiac surgeons and cardiologists in order to ensure patient safety and well-being in the perioperative period.
Cardiovascular nurses and the interprofessional team work 
to create an environment rich in quality-care improvements, 
professional experience and progressive learning opportunities. 
A shared governance model ensures that nurses and 
interprofessionals who practice patient care have a strong voice 
in decisions that affect their practice. As a three-time Magnet-
recognized facility, MMC is in the top two percent in the country 
and our nurses pursue excellence in their care of patients.
OR team (with Surgical Technologist Susan Nelson 
facing) preparing for a pediatric cardiac surgery
Pictured, left to right, 
Julie Salvatelli, PA; 
Kimberly Malka, MD; 
Nathan Aranson, MD; 




Cardiovascular Services at MaineHealth is a leader in education and research in northern New England. MMC has 
a long tradition of excellence in education with a full complement of residency and fellowship programs, along with 
ACGME-accredited training programs in Cardiovascular Medicine and Vascular Surgery. Our physicians, nurses and 
scientists participate in clinical trials. We are actively involved in multidisciplinary research efforts in basic and translational 
science at the Maine Medical Center Research Institute (MMCRI), population science and epidemiology at the Center 
for Outcomes Research (CORE) and education research at the Maine Institute for Teaching Excellence (MITE). This 
year our highlights include:
• Access to Cardiac Clinical Trials in Rural Areas        
Robert Kramer, MD, Director of Cardiac Surgery Research and Quality Improvement at MMC, and Alexander 
Iribarne, MD, MS, cardiac surgeon and Director of Cardiac Surgery Research at Dartmouth-Hitchcock Medical 
Center (DHMC) are principal investigators on a $3.9-million grant from the National Institute of Health’s 
National Heart, Lung and Blood Institute (NHLBI). This grant will establish a collaborative network to increase 
access to cardiac surgery clinical trials among rural populations. MMC and DHMC are now linked Clinical 
Research Centers that support the NIH Cardiothoracic Surgical Trials Network. The grant will have a significant 
impact on rural cardiac surgery patients in Maine and New Hampshire, states with the oldest populations in the 
nation, according to the most recent U.S. Census data. Maine is also the state with the highest percentage of its 
population living in rural or non-metropolitan areas. People residing in rural areas of northern New England 
have higher-than-average rates of cardiovascular disease. 
PATIENT CHANGES CAREER, INSPIRED BY THE 
DOCTOR WHO SAVED HER LIFE 
Monica Salamone is a mother of two, and it wasn’t long after 
the birth of her younger son that her life took a dramatic 
turn. Monica was living with a congenital heart condition 
that hadn’t caused any major issues. One day at home she 
collapsed, and her husband called 911. Monica’s heart was 
struggling to beat. Within her chest, the inner layer of the 
aorta (the large blood vessel branching off the heart) had 
torn. Blood was surging through the tear, causing the inner 
and middle layers of the aorta to separate — a very serious 
and usually fatal condition called an aortic dissection. 
Because Monica needed emergency open-heart surgery, 
she was transported from Southern Maine Health Care 
(SMHC) to MMC by ambulance. Cardiothoracic surgeon 
Scott Buchanan, MD, performed Monica’s operation. He later told her the team at SMHC and the paramedics who 
responded to her husband’s 911 call had done everything perfectly right, and that their actions were key to saving her 
life. Monica benefitted from a coordinated system of care within the MaineHealth family of providers.
Monica had a chance to go back to school and decided to change the course of her career. She recently became a 
cardiovascular radiologic technologist and part of the MMC cardiovascular team. Monica now works alongside the 
doctor who saved her life.
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• $1.9M Awarded to Study Cardiac Cell Therapy in Maine        
Medical Center Chief Academic Officer, Doug Sawyer, MD, PhD, and MMCRI Faculty Scientist Calvin Vary, 
PhD, are the principal investigators on a $1.9-million grant from the NHLBI to study how certain adult stem 
cells might be used to reverse heart failure when injected into the heart. The research team is looking into whether 
certain kinds of heart cells might be more effective than others in regenerating heart tissue when injected into 
a failing heart.
• Anti-Aging Diets Impact Vascular Health          
Obesity is a risk factor for the accelerated development of cardiovascular disease, and a steady increase in obesity, 
particularly in youth, has made this condition a major public health problem. MMCRI faculty scientist Lucy 
Liaw, PhD is taking a closer look at diets and cardiovascular disease, thanks to her recent Transformational 
Project Award from the American Heart Association (AHA). The major problem the lab will address is why 
obesity and fat expansion lead to greater occurrence or severity of vascular disease. This research will study how 
anti-aging diets impact fat surrounding blood vessels and vascular health. Long-term results from studies like 
Dr. Liaw’s could lead to potential therapies to increase health and reverse the effects of cardiovascular disease.
• Can Resveratrol Help Patients with Diabetes and Heart Disease?      
Diabetes prevents efficient metabolism of fuel, causes inflammation and vascular disease that blocks normal 
blood flow and inhibits the function of the heart after injury. These changes make diabetics more susceptible to 
heart attacks and heart failure. AHA leads the fight against diabetes and heart disease. MMC cardiac surgeon 
Michael Robich, MD, received a Mentored Clinical & Population Research Award from the AHA, with Dr. 
Doug Sawyer serving as mentor. This project is a unique collaboration among cardiologists, cardiac surgeons 
and other scientists. In the first phase of this study, physicians have been safely collecting tissue from the hearts 
of patients undergoing heart surgery. In 2019 the second phase of the study began, which included enrolling 
patients to examine how resveratrol changes the metabolic profile of the heart. Understanding how the heart is 
impacted by diabetes and reversing its negative effects could lead to decreased rates of heart failure and death 
in diabetic patients and could offer new treatment options.
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COORDINATION OF CARE KEEPS PATIENT MOVING
John “Kenny” Kramer is the kind of guy who just doesn’t stop moving. He never had any major health issues until one day, 
after carrying ten 40-pound bags of wood pellets into his shed, he collapsed at the kitchen sink. Almost immediately, Kenny 
regained consciousness. But his wife arranged for an ambulance to take him to the SMHC Emergency Department for a CT 
scan. Once the scan was complete, Dr. Sarah Shepherd determined Kenny was suffering from a large, ruptured abdominal 
aortic aneurysm, at which point he was airlifted to MMC for emergency surgery led by vascular surgeon Paul Bloch, MD. 
Kenny had an enlarged blockage in his abdomen that was preventing crucial blood flow, and it needed attention right away.
The surgery saved Kenny’s life. The next morning he was on his way home, and within a month he was back to walking 
two miles a day. “I had no symptoms whatsoever,” Kenny says. “I remember going to the ED in Sanford, and that’s about 
it until I spoke with Dr. Bloch at MMC. The coordination between the care teams was wonderful.”
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MaineHealth is committed to knowledge sharing and the ongoing 
discussion of our cardiovascular best practices, clinical guidelines, research 
and outcomes. In the past year, we’ve organized valuable resources for both 
our regional network of cardiovascular care providers and for other health 
care professionals who are interested in referring a patient to our care. For 
more information, visit:
https://mainehealth.org/services/cardiovascular/provider-resources
• Care protocols and referral guidelines
• Innovation videos
• Provider interviews and case studies
• Outcomes reporting
• Provider education
PROVIDER RESOURCES AND RECOGNITION
MAINEHEALTH HAS RECEIVED 
 SYSTEMWIDE ACCREDITATION FOR 
OUR ECHOCARDIOGRAPHY SERVICE












LINCOLN MEDICAL PARTNERS 
CARDIOLOGY, MILES CAMPUS
Damariscotta 207-563-4811
MAINE MEDICAL PARTNERS 




North Conway, NH 207-885-9905
FRANKLIN MEMORIAL HOSPITAL 
(MAINE MEDICAL PARTNERS)
Farmington 207-779-3120
SOUTHERN MAINE HEALTH CARE 
(MAINE MEDICAL PARTNERS)
Biddeford/Sanford 207-282-3666
WALDO COUNTY MEDICAL PARTNERS 
CARDIOVASCULAR MEDICINE
Belfast 207-505-4675
STEPHENS MEMORIAL, WESTERN MAINE 
HEALTH (MAINE MEDICAL PARTNERS)
Norway 207-885-9905
REDINGTON-FAIRVIEW GENERAL HOSPITAL 
(MAINE MEDICAL PARTNERS)
Skowhegan 207-872-1800
MID COAST CARDIOLOGY 
Brunswick 207-729-7939
 VASCULAR SURGERY





SOUTHERN MAINE HEALTH CARE VASCULAR 
SERVICES
Biddeford 207-282-3666
MAINE MEDICAL PARTNERS VEIN PROGRAM
Scarborough 207-662-0909
 CARDIOVASCULAR SURGERY




MAINE MEDICAL PARTNERS — 
CONGENITAL HEART
Portland 207-883-5532
MAINEHEALTH.ORG/CARDIOVASCULAR
